Clinical trials on novel drug therapies require clear criteria for patient selection and agreed definitions of disease remission. This principle has been successfully applied in the field of rheumatology where agreed disease scoring systems have allowed multi-centre collaborations and facilitated audit across treatment centres. Unfortunately in ulcerative colitis this consensus is lacking. Thirteen scoring systems have been developed but none have been properly validated. Most trials choose d...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation.
If you are the owner of this record, you can report an update to it here: Report update to this record